While read across offers numerous advantages, it also presents several challenges:
Uncertainty: Predicting toxicity based on analogues can introduce uncertainties, particularly when the structural similarity is not optimal. Data availability: The approach relies heavily on the availability of high-quality data for the source chemicals. Regulatory scrutiny: Regulatory agencies may require extensive justification and evidence to accept read across conclusions, making the process time-consuming.
